Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.25 USD
Change Today 0.00 / 0.00%
Volume 25.5K
SNGX On Other Exchanges
As of 8:10 PM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David M. Kent BA (Hons) 1st Class, MAICD

AgeTotal Calculated CompensationThis person is connected to 0 board members in 1 different organizations across 4 different industries.



Mr. David M. Kent, BA (Hons) 1st Class, MAICD served as Chief Executive Officer and President of Soligenix, Inc. from January 2003 to March 2003. Mr. Kent served as Chief Financial Officer and Founder of Arriva Pharmaceuticals, Inc., from 1997 to September 2002. While at Arriva, he was successful in-licensing intellectual property from a variety of corporate, private and public institutions. From 1996 to 1997, prior to founding Arriva, he was a Principal founder of Ventec, ...

Read Full Background

Corporate Headquarters*

29 Emmons Drive
Princeton, New Jersey 08540

United States

Phone: 609-538-8200
Fax: 609-452-6467

Board Members Memberships*



University Of Sydney

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SNGX:US $1.25 USD 0.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SOLIGENIX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at